The Joint Corp. JYNT · Stock Open The Joint Corp. in new tab
The Joint Corp. Analysis (JYNT)
Is The Joint Corp. a good investment? The Joint Corp. (JYNT) is currently trading at 8.21 USD. Market analysts have a consensus price target of 10.00 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 92.11. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: The Joint Corp. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 0.43.
Investor FAQ
Does The Joint Corp. pay a dividend?
No, it does not currently pay a dividend.
What asset class is The Joint Corp.?
The Joint Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.09.
Company Profile
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Community Discussion